Research map: Myeloid cell reprogramming combined with zoledronic acid effectively suppresses bone metastasis
Back to the article
Papers in this map
ITGB3/CD61: a hub modulator and target in the tumor microenvironment. · Chen Zhu · 2019 · 78 citations · Cited by this paper
Click chemistry-driven tumor theranostics: recent advances, challenges, and future perspectives
· 2026 · Related
Cancer-immunity cycle-based molecular subtypes in breast cancer predict the response to immune checkpoint inhibitors
· 2026 · Related
Artificial intelligence empowering precision diagnosis and treatment of breast cancer: advancing global clinical practice with regional insights
· 2026 · Related
Apatinib enhances targeted immunotherapy via the IL-6-gp130-PI3K pathway in HER2-positive gastric cancer
· 2026 · Related
NSAIDs for PI3K-altered head and neck cancer: a biomarker-driven therapeutic opportunity
· 2026 · Related
Anogenital human papillomavirus infection patterns by anatomical site and sexual orientation in Chinese men: a national multi-center study
· 2026 · Related
Enhancing FIT-based colorectal cancer screening through risk prediction: a comparative evaluation of 17 models in a large Chinese cohort
· 2026 · Related
Genetic susceptibility, environmental risk factors, and incident gastric cancer risk among individuals with different Helicobacter pylori infection status: a population-based study
· 2026 · Related
A foundation model-enhanced CT radiomics signature for the noninvasive assessment of tertiary lymphoid structures and prediction of therapy benefit in gastric cancer
· 2026 · Related
Induction immunochemotherapy followed by definitive radiotherapy in patients with limited-stage small cell lung cancer: a multicenter study
· 2026 · Related
Source: OpenAlex (CC0)